Introduction {#sec1_1}
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The use of lasers to remove tattoos was an important advance in dermatology. Quality-switched lasers emit short pulses of light (nanoseconds) to fragment pigments through selective photothermolysis \[[@B1], [@B2], [@B3], [@B4]\]. They are considered the gold standard for tattoo removal \[[@B3]\]. Skin hypopigmentation is one of the potential side effects of laser tattoo removal. This is more common in tanned skins or with the use of lasers with wave lengths of 532 or 694 nm \[[@B2]\]. Hypopigmentation, which is thought to be caused by the destruction of melanin in the basal cell layer, is usually transient and repigmentation can occur spontaneously over time \[[@B1]\]. However, achromic areas can improve with sun exposure or phototherapy \[[@B2]\]. Scars can also appear in laser-treated areas and it may be difficult to make a clinical distinction between achromic patches and achromic scars \[[@B1], [@B2]\]. Achromic scars are caused by the use of high-energy lasers in intensely pigmented areas or by multiple laser treatments in the same area \[[@B1], [@B3], [@B4]\]. Achromic scars can appear after the first laser sessions or develop only after the complete removal of the tattoo pigment \[[@B2]\]. As with any scar, these lesions are difficult to treat because they do not repigment over time or with phototherapy. Moreover, since these scars are very superficial, intralesional infiltration is technically difficult.

We present a simple and original solution to repigment achromic laser tattoo removal scars. In 2004, Fulton et al. \[[@B5]\] reported the successful repigmentation of hypochromic scars using a multi-step technique to remove areas of hypopigmentation associated with dermal fibrosis. This led us to search for a simpler and less invasive method to remove this type of fibrosis. We propose the delivery of anti-fibrotic agents into the superficial dermis using MMP® ("Microinfusão de Medicamentos na Pele," Portuguese acronym for "Microinfusion of Drugs in the Skin") \[[@B6]\], a recently described microinfusion drug delivery technique that uses needling and a tattoo machine. Tattoos are undeniable proof that this is an effective method to "inject" chemical substances into the dermis. MMP® has been successfully used to repigment idiopathic guttate hypomelanosis \[[@B7]\].

Case Report {#sec1_2}
===========

In April 2014, a 49-year-old man, Fitzpatrick skin phototype III, complained of achromic scars in his left deltoid region (Fig. [1a](#F1){ref-type="fig"}) after 18 laser tattoo removal sessions (with Q-Switched 755 and 1064). We injected an endovenous solution (50 mg/mL) of 5-fluorouracil (5-FU) in the achromic scars using the MMP® drug delivery technique. During the procedures, in the area adjacent to the injection site, we noticed the accumulation of a white powder compatible with 5-FU drug delivery \[[@B8]\]. After five MMP® sessions (with 1-month intervals), the scars were completely repigmented (Fig. [1](#F1){ref-type="fig"} and [2](#F2){ref-type="fig"}). Appearance remained unchanged 3 years after the last session.

Discussion {#sec1_3}
==========

This case shows the successful use of a novel, simple, and inexpensive method to repigment achromic laser tattoo removal scars.

Patients who seek laser treatment to eliminate their tattoos expect a near perfect result. They usually arrive knowing (from information available in the media) that it will take several sessions to remove the tattoo and that laser treatment may not eliminate all the pigments. However, most are unaware that laser treatments can have permanent side effects, even when the dermatologist uses the best available technique and equipment \[[@B1], [@B2], [@B3], [@B4]\]. Despite this information, most patients react negatively and demand a solution when achromic scars appear during or soon after laser tattoo removal treatment. Delivery of 5-FU into achromic scars using the MMP® technique is an easily available, effective, and inexpensive solution for these cases. The area submitted to drug delivery was 2 cm^2^, so we estimated \[[@B9]\] that 2,350 μg of 5-FU was injected per session, a dose considered safe and far lower than that used for intravenous chemotherapy \[[@B10]\]. The esthetic results of the procedure can help to reduce patients\' frustrations and complaints about one of the side effects of laser tattoo removal treatment. We have been successfully using this drug delivery technique in our daily practice to repigment achromic scars over the last 3 years.

We hypothesize that the anti-fibrotic properties of 5-FU reduce fibrosis in the papillary dermis and stimulate melanogenesis. Moreover, 5-FU may also have a direct effect on melanocytes and stimulate repigmentation\[[@B11]\].

Other drugs, such as corticosteroids, bleomycin, or mitomycin C \[[@B12]\], could be tested to repigment scars using this drug delivery technique.
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![Achromic laser tattoo scars. **a** Baseline achromic scars in left deltoid region after 18 laser tattoo removal treatment sessions. Note: The patient was suntanned. **b** Same area after five MMP® sessions with 5-FU.](cde-0011-0140-g01){#F1}

![Achromic laser tattoo scars. **a**, **b** Images using the Antera 3D® colorimetry system at baseline (**a**), and after three MMP® sessions with 5-FU (**b**). The areas outlined in black correspond to where we assessed melanin levels using the Antera 3D® software (**c**). **c** Average melanin level in **a** (red bar) and **b** (blue bar) using the Antera 3D® software.](cde-0011-0140-g02){#F2}
